An increase in cardiac P-adrenergic sensitivity or 8-receptor density or both has been described in several animal species after denervating the heart. The transplanted human heart is also denervated and, therefore, may exhibit supersensitivity to /3-adrenergic agonists and an increase in .3-adrenergic receptor density. In 16 patients examined 1-3 months after orthotopic cardiac transplantation, /3-adrenergic receptor density measured by [t211]iodocyanopindolol binding in endomyocardial biopsy specimens was not significantly different in transplant recipients compared with normal controls (transplant=1,429±199, control=1,728±263 fmol/g wet wt; p=NS). However, when normalized to Lowry protein, the ['25lliodocyanopindolol in ,8-adrenergic receptor density in biopsy tissue from transplant recipients was significantly lower than in tissue from controls (transplant=58.1+6.2, control=93.5+13.4 fmol/g Lowry protein; p = 0.011). Atrial sinus node activity of the denervated donor heart and the innervated atrial cuf of the native recipient heart could be detected on the surface electrocardiogram in six patients. In these six patients, the heart rate response to graded infusions of epinephrine (taken up by the adrenergic nerve terminals) and isoproterenol (not taken up by the adrenergic nerve terminals) was measured. The epinephrine dose-response curve in transplanted donor atria was significantly to the left of the native recipient atrial dose-response curve (p < 0.0001). The isoproterenol dose-response curves for native and transplanted atria were not different. We conclude that myocardial 3-adrenergic receptors are not increased in human orthotopic cardiac allografts and that there is no evidence for /3-receptor-mediated supersensitivity of postsynaptic origin. However, human orthotopic cardiac allografts exhibit adrenergic supersensitivity of the sinus node to agents that are ordinarily removed by the neuronal uptake system. This supersensitivity is, therefore, presynaptic in origin and should increase the response of the transplanted heart to circulating epinephrine or norepinephrine. (Circulation 1989;79:344-349) W e have reported that rabbit and rat heterotopic cardiac allografts analyzed 4 weeks after transplantation have increased f3-adrenergic receptor density and increased isoproterenol-stimulated adenylate cyclase activity presumably due to denervation.1 An increase in cardiac 8-adrenergic sensitivity or 8-receptor density has also been described in several other animal species after denervation of the heart.2-5 Although the heart of human cardiac transplant recipients has been shown to be denervated,6-8 early studies with small numbers of subjects did not demonstrate From the Utah Cardiac Transplant Program, Salt Lake City, Utah.